Fractal Therapeutics logo — Model-based drug discovery & development services, helping c...

Fractal Therapeutics

Model-based drug discovery & development services, helping clients get candidate drug molecules to market faster.

Founded 2016 United States Cambridge, United States 6 employees Biotechnology, Health and Wellness +1

General Information

Company Name Fractal Therapeutics
Founded Year 2016
Location United States Cambridge, United States +1
Employees 6
Industries Biotechnology, Health and Wellness, Life Sciences
Social

Get notified when Fractal Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Fractal Therapeutics

Fractal Therapeutics makes model-based drug development more than just a set of buzzwords. In our hands, modeling underpins a practical cross-disciplinary approach to accelerating drug R&D. We engage on a target and modality-exclusive basis with early-stage partners on their programs, using our approaches to provide robust model-based answers to critical-path questions on the road to new asset creation and development. Our work couples mathematical modeling tightly with carefully designed animal studies and clinical trials. Fractal's model-based analyses and preclinical strategies help clients put together a more rigorous Investigational New Drug application and be more successful in early clinical development. Our team at Fractal is made up of drug developers who know how to use modeling to advance a drug quickly and efficiently. Taking an engineering approach, we frame questions in drug R&D in terms of quantitative analyses that can often be addressed with existing experimental data, allowing more progress for each unit of experimental effort. For more details, visit us at http://www.fractaltx.com

Taxonomy: Drug discovery, Drug development, Model-based approach, Mathematical modeling, Preclinical strategies, Clinical trials, Pharmacokinetics, Pharmacodynamics, Oncology, Infectious disease, Investigational New Drug application, Biotech companies, Scientific feedback, Cross-disciplinary approach, Early-stage partners

No funding data available for Fractal Therapeutics yet.

Get notified when Fractal Therapeutics raises funding

Fractal Therapeutics Alternatives & Competitors

Fractal Therapeutics vs
Applied BioMath
Applied BioMath United States

Model-Informed Drug Discovery and Development (MID3) services, software, and R&D company.

Grant
31 employees
Biotechnology, Medical Devices
Fractal Therapeutics vs
RES Group, Inc
RES Group, Inc United States

Mechanistic modeling & simulation services to accelerate R&D in drug development

24 employees
Energy, Pharmaceutical
Fractal Therapeutics vs

REINVENTING CARDIAC DRUG DISCOVERY

Seed
22 employees
Biotechnology

FAQ About Fractal Therapeutics

Model-based drug discovery & development services, helping clients get candidate drug molecules to market faster.
Fractal Therapeutics was founded in 2016.
Fractal Therapeutics is headquartered in Cambridge, United States.
Fractal Therapeutics operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
Fractal Therapeutics has approximately 6 employees.
Top alternatives and competitors to Fractal Therapeutics include Applied BioMath, RES Group, Inc, HeartBeat.bio AG, Cloudbreak Therapeutics, Origent Data Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Fractal Therapeutics and Applied BioMath are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Fractal Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy